adenosine has been researched along with Pulmonary Arterial Remodeling in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, NT; Nandurkar, HH; Sashindranath, M; Willcox, A | 1 |
| Andrade, JG; Badra-Verdu, M; Champagne, J; Deyell, MW; Dubuc, M; Jolly, U; Khairy, P; Leong-Sit, P; Macle, L; Nattel, S; Sapp, J; Verma, A | 1 |
| Joolharzadeh, P; St Hilaire, C | 1 |
| Amione-Guerra, J; Blackburn, MR; Bruckner, BA; Bunge, RR; Chen, NY; Davies, J; Eltzschig, HK; Garcia-Morales, LJ; Karmouty-Quintana, H; Loebe, M; Luo, F; Melicoff, E; Pandit, LM; Philip, K; Volcik, KA; Weng, T | 1 |
| Anyanwu, AC; Burant, CF; Goonewardena, SN; Hyman, MC; Kanthi, Y; Petrovic-Djergovic, D; Pinsky, DJ; Rattan, R; Robichaud, P; Visovatti, SH; Wang, J | 1 |
2 review(s) available for adenosine and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
CD39 in the development and progression of pulmonary arterial hypertension.
Topics: Adenosine; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Pulmonary Arterial Hypertension; Vascular Remodeling | 2022 |
CD73 (Cluster of Differentiation 73) and the Differences Between Mice and Humans.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Clinical Trials as Topic; Disease Models, Animal; GPI-Linked Proteins; Humans; Inflammation; Joint Diseases; Mice, Knockout; Molecular Targeted Therapy; Neoplasms; Phenotype; Species Specificity; Thrombophilia; Tunica Media; Vascular Calcification; Vascular Diseases; Vascular Remodeling | 2019 |
1 trial(s) available for adenosine and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Prevalence and clinical impact of spontaneous and adenosine-induced pulmonary vein reconduction in the Contact-Force vs. Cryoballoon Atrial Fibrillation Ablation (CIRCA-DOSE) study.
Topics: Adenosine; Atrial Fibrillation; Cryosurgery; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Pulmonary Veins; Single-Blind Method; Vascular Remodeling; Vasodilator Agents | 2020 |
2 other study(ies) available for adenosine and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary Hypertension.
Topics: Adenosine; Aged; Female; Humans; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Pulmonary Fibrosis; Vascular Remodeling | 2016 |
Purinergic dysregulation in pulmonary hypertension.
Topics: Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Antihypertensive Agents; Apyrase; Arterial Pressure; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Hydrolysis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Pulmonary Artery; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X1; Severity of Illness Index; Signal Transduction; Suramin; Vascular Remodeling; Ventricular Remodeling | 2016 |